Deutsche Biotech Innovativ AG

DUSE:DBI Stock Report

Market Cap: €1.3m

Deutsche Biotech Innovativ Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Bernd Wegener

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

What Kind Of Investors Own Most Of Deutsche Biotech Innovativ AG (DUSE:DBI)?

Feb 17
What Kind Of Investors Own Most Of Deutsche Biotech Innovativ AG (DUSE:DBI)?

Deutsche Biotech Innovativ (DUSE:DBI) Is In A Good Position To Deliver On Growth Plans

Dec 02
Deutsche Biotech Innovativ (DUSE:DBI) Is In A Good Position To Deliver On Growth Plans

CEO

Bernd Wegener (76 yo)

no data

Tenure

Dr. Bernd Wegener, FRICS, serves as the Chairman of Management Board and Chief Executive Officer at Deutsche Biotech Innovativ AG. Dr. Wegener served as Chairman of the Supervisory Board of Adrenomed AG un...


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.